Yes—people with three inflammatory diseases had more immune-cell clumps, but the cells involved differed by disease. The study compared people with COVID-19, rheumatoid arthritis, or lupus with healthy people. Rheumatoid arthritis and lupus are diseases where immune defenses attack healthy tissue. Researchers used special blood tests to identify cells joined to Platelets, the tiny blood parts that help form clots. They also tested how readily these cells formed more clumps. All three disease groups had more clumps than the healthy group. In rheumatoid arthritis and lupus, clumps mainly involved monocytes. These immune cells help fight infection and clear damaged tissue. In COVID-19, clumps mainly involved neutrophils, another type of immune cell. Images also showed large groups of clot-forming cells attached to one or two neutrophils. The source summary gives no group sizes or exact increases. When researchers strongly stimulated the blood samples, the disease groups formed fewer additional clumps above their starting levels. The researchers saw this as a sign that immune cells were less able to respond. More clumps did not mean a stronger response. For members tracking Monocytes (Absolute), the key distinction is count versus behavior. This study examined how cells joined together, not just how many were present. It does not show that a higher routine count means more clumps. When comparing bloodwork with the community, dates and notes about illness can give numbers useful context. Your routine count alone cannot reveal the cell behavior measured here. What changes have you noticed in your numbers around illness or periods of inflammation?